Exhibit 32

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of Allergy Research Group, Inc.
(the "Company") on Form 10-QSB for the period ending September 30, 2005 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Dr. Stephen A. Levine, Chief Executive Officer and Chief Financial Officer of
the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to
ss.906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

          (1) The Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

          (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: November 10, 2005


                                         By: /s/ Stephen A. Levine
                                             ---------------------------------
                                             Dr. Stephen A. Levine
                                             Chief Executive Officer and
                                             Chief Financial Officer

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to Allergy Research Group, Inc. and
will be retained by Allergy Research Group, Inc. and furnished to the Securities
and Exchange Commission or its staff upon request.